Related by context. Frequent words. (Click for all words.) 62 placebo controlled randomized 59 Phase III randomized 58 multicenter randomized double 58 placebo controlled clinical 58 subgroup analyzes 57 active comparator 56 prospective observational 56 placebo controlled trials 55 randomized Phase III 55 blind randomized controlled 55 irbesartan 55 TRITON TIMI 55 double blinded placebo 55 myocardial infarction stroke 55 multicenter randomized 54 placebo controlled studies 54 multicentre 54 myocardial infarctions 53 secondary efficacy endpoints 53 NCT# 53 composite endpoint 53 fasting glucose levels 53 dose regimens 53 coronary revascularization 53 randomized controlled clinical trials 52 blind randomized placebo 52 serum uric acid 52 randomized controlled clinical 52 systemic embolism 52 randomized placebo controlled 52 multicenter study 52 PROPEL trial 52 myocardial infarction MI 52 congenital malformations 52 blinded placebo controlled 52 prospective randomized 52 epidemiologic studies 52 multicenter clinical 52 placebo controlled 52 dose cohorts 52 randomized controlled 52 Board DSMB 51 events SAEs 51 tolvaptan 51 randomized double 51 Pivotal Trial 51 Multaq R 51 observational studies 51 HbA1c levels 51 discontinuations due 51 SPIRIT III 51 Pivotal Phase III 51 blind randomized 51 Rosuvastatin 51 dose escalation trial 51 plus prednisone 50 deforolimus 50 multicenter 50 Completes Enrollment 50 prospective randomized controlled 50 Multicenter 50 Mylotarg 50 renal dysfunction 50 meta analyzes 50 Secondary endpoints 50 cardiovascular mortality 50 rosuvastatin 50 left ventricular hypertrophy 50 ataluren 50 neuropsychiatric symptoms 50 NSABP 50 safinamide 50 retrospective cohort study 49 elevated triglycerides 49 JANUVIA 49 6R BH4 49 RRMS patients 49 FOLFIRI 49 registrational trial 49 DSMB 49 ocular hypertension 49 double blind placebo 49 Amrubicin 49 mixed dyslipidemia 49 ONGLYZA 49 label dose escalation 49 fasting glucose 49 pertuzumab 49 KRAS mutations 49 LEXIVA 49 fasting insulin 49 elagolix 49 substudy 49 patients evaluable 49 Phase Ib 49 estrogen progestin 49 virologic failure 49 MIRCERA 48 HbA 1c 48 SCH # 48 Pivotal Phase